24 related articles for article (PubMed ID: 10414564)
1. Stem cell therapy for chronic obstructive pulmonary disease.
Chen YT; Miao K; Zhou L; Xiong WN
Chin Med J (Engl); 2021 Jun; 134(13):1535-1545. PubMed ID: 34250959
[TBL] [Abstract][Full Text] [Related]
2. Emphysema: A Potential Risk Factor for Subarachnoid Hemorrhage and Ruptured Aortic Aneurysm.
Mahta A; Merkler AE; Reznik ME; Burch JE; Yaghi S; Sellke FW; Furie KL; Kamel H
Stroke; 2019 Apr; 50(4):992-994. PubMed ID: 30885079
[TBL] [Abstract][Full Text] [Related]
3. Elastin degradation in the superficial temporal arteries of patients with intracranial aneurysms reflects changes in plasma elastase.
Connolly ES; Fiore AJ; Winfree CJ; Prestigiacoma CJ; Goldman JE; Solomon RA
Neurosurgery; 1997 May; 40(5):903-8; discussion 908-9. PubMed ID: 9149247
[TBL] [Abstract][Full Text] [Related]
4. Serum elastase and alpha-1-antitrypsin levels in patients with ruptured and unruptured cerebral aneurysms.
Baker CJ; Fiore A; Connolly ES; Baker KZ; Solomon RA
Neurosurgery; 1995 Jul; 37(1):56-61; discussion 61-2. PubMed ID: 8587691
[TBL] [Abstract][Full Text] [Related]
5. Activity of alpha 1-antitrypsin and cigarette smoking in subarachnoid haemorrhage from ruptured aneurysm.
Gaetani P; Tartara F; Tancioni F; Klersy C; Forlino A; Baena RR
J Neurol Sci; 1996 Sep; 141(1-2):33-8. PubMed ID: 8880689
[TBL] [Abstract][Full Text] [Related]
6. Metalloproteases and intracranial vascular lesions.
Gaetani P; Rodriguez y Baena R; Tartara F; Messina AL; Tancioni F; Schiavo R; Grazioli V
Neurol Res; 1999 Jun; 21(4):385-90. PubMed ID: 10406011
[TBL] [Abstract][Full Text] [Related]
7. Alpha 1-antitrypsin activity in subarachnoid hemorrhage.
Tartara F; Gaetani P; Tancioni F; Guagliano A; Klersy C; Forlino A; Marzatico F; Rodriguez y Baena R
Life Sci; 1996; 59(1):15-20. PubMed ID: 8684266
[TBL] [Abstract][Full Text] [Related]
8. Absence of plasma protease-antiprotease imbalance in the formation of saccular cerebral aneurysms.
Sakai N; Nakayama K; Tanabe Y; Izumiya Y; Nishizawa S; Uemuara K
Neurosurgery; 1999 Jul; 45(1):34-8; discussion 38-9. PubMed ID: 10414564
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of intracranial aneurysms during pregnancy].
Mosiewicz A; Jakiel G; Janusz W; Markiewicz P
Ginekol Pol; 2001 Feb; 72(2):86-92. PubMed ID: 11387996
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of ruptured distal middle cerebral artery aneurysms: Review of the literature.
Tsutsumi K; Horiuchi T; Nagm A; Toba Y; Hongo K
J Clin Neurosci; 2017 Jun; 40():14-17. PubMed ID: 28087184
[TBL] [Abstract][Full Text] [Related]
11. Clinical decision making in intracranial aneurysms and aneurysmal subarachnoid hemorrhage--science and art.
Piepgras DG
Clin Neurosurg; 1992; 39():68-75. PubMed ID: 1458758
[No Abstract] [Full Text] [Related]
12. Protease-antiprotease interactions and the rationale for therapeutic protease inhibitors.
Schmid S; Uhl W; Büchler MW
Scand J Gastroenterol Suppl; 1996; 219():47-50. PubMed ID: 8865472
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
